English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

The 15q24.1 locus, including  CYP1A2 , is associated with blood pressure (BP). The  CYP1A2 rs762551 C  allele is associated with lower CYP1A2 enzyme activity. CYP1A2 metabolizes caffeine and is induced by smoking. The association of caffeine consumption with hypertension remains controversial. We explored the effects of  CYP1A2  variants and CYP1A2 enzyme activity on BP, focusing on caffeine as the potential mediator of  CYP1A2  effects. Four observational ( n  = 16 719) and one quasi-experimental studies ( n  = 106) including European adults were conducted. Outcome measures were BP, caffeine intake, CYP1A2 activity and polymorphisms rs762551, rs1133323 and rs1378942.  CYP1A2  variants were associated with hypertension in non-smokers, but not in smokers ( CYP1A2 -smoking interaction  P  = 0.01). Odds ratios (95% CIs) for hypertension for rs762551 CC, CA and AA genotypes were 1 (reference), 0.78 (0.59–1.02) and 0.66 (0.50–0.86), respectively,  P  = 0.004. Results were similar for the other variants. Higher CYP1A2 activity was linearly associated with lower BP after quitting smoking ( P  = 0.049 and  P  = 0.02 for systolic and diastolic BP, respectively), but not while smoking. In non-smokers, the  CYP1A2  variants were associated with higher reported caffeine intake, which in turn was associated with lower odds of hypertension and lower BP ( P  = 0.01). In Mendelian randomization analyses using rs1133323 as instrument, each cup of caffeinated beverage was negatively associated with systolic BP [−9.57 (−16.22, −2.91) mmHg]. The associations of  CYP1A2  variants with BP were modified by reported caffeine intake. These observational and quasi-experimental results strongly support a causal role of CYP1A2 in BP control via caffeine intake.

Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension